BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18223694)

  • 21. Phosphorylation accelerates geldanamycin-induced Akt degradation.
    Su CH; Lan KH; Li CP; Chao Y; Lin HC; Lee SD; Lee WP
    Arch Biochem Biophys; 2013 Aug; 536(1):6-11. PubMed ID: 23668972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Inhibition of Heat Shock Protein 90 Facilitates the Degradation of Poly-Alanine Expanded Poly (A) Binding Protein Nuclear 1 via the Carboxyl Terminus of Heat Shock Protein 70-Interacting Protein.
    Shi C; Huang X; Zhang B; Zhu D; Luo H; Lu Q; Xiong WC; Mei L; Luo S
    PLoS One; 2015; 10(9):e0138936. PubMed ID: 26414348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent.
    Whitesell L; Sutphin PD; Pulcini EJ; Martinez JD; Cook PH
    Mol Cell Biol; 1998 Mar; 18(3):1517-24. PubMed ID: 9488468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHIP chaperones wild type p53 tumor suppressor protein.
    Tripathi V; Ali A; Bhat R; Pati U
    J Biol Chem; 2007 Sep; 282(39):28441-28454. PubMed ID: 17666403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells.
    Lin K; Rockliffe N; Johnson GG; Sherrington PD; Pettitt AR
    Oncogene; 2008 Apr; 27(17):2445-55. PubMed ID: 17982489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hsp90 chaperones wild-type p53 tumor suppressor protein.
    Walerych D; Kudla G; Gutkowska M; Wawrzynow B; Muller L; King FW; Helwak A; Boros J; Zylicz A; Zylicz M
    J Biol Chem; 2004 Nov; 279(47):48836-45. PubMed ID: 15358769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
    Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
    Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells.
    Kang SA; Cho HS; Yoon JB; Chung IK; Lee ST
    Biochem J; 2012 Oct; 447(2):313-20. PubMed ID: 22849407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E3 ligase CHIP and Hsc70 regulate Kv1.5 protein expression and function in mammalian cells.
    Li P; Kurata Y; Maharani N; Mahati E; Higaki K; Hasegawa A; Shirayoshi Y; Yoshida A; Kondo T; Kurozawa Y; Yamamoto K; Ninomiya H; Hisatome I
    J Mol Cell Cardiol; 2015 Sep; 86():138-46. PubMed ID: 26232501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma.
    Ayrault O; Godeny MD; Dillon C; Zindy F; Fitzgerald P; Roussel MF; Beere HM
    Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17037-42. PubMed ID: 19805107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.
    Zhang HT; Zeng LF; He QY; Tao WA; Zha ZG; Hu CD
    Biochim Biophys Acta; 2016 Feb; 1863(2):335-46. PubMed ID: 26658161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoplasmic reticulum-associated degradation of Niemann-Pick C1: evidence for the role of heat shock proteins and identification of lysine residues that accept ubiquitin.
    Nakasone N; Nakamura YS; Higaki K; Oumi N; Ohno K; Ninomiya H
    J Biol Chem; 2014 Jul; 289(28):19714-25. PubMed ID: 24891511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsp70- and Hsp90-Mediated Regulation of the Conformation of p53 DNA Binding Domain and p53 Cancer Variants.
    Boysen M; Kityk R; Mayer MP
    Mol Cell; 2019 May; 74(4):831-843.e4. PubMed ID: 31027880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gambogic acid-induced degradation of mutant p53 is mediated by proteasome and related to CHIP.
    Wang J; Zhao Q; Qi Q; Gu HY; Rong JJ; Mu R; Zou MJ; Tao L; You QD; Guo QL
    J Cell Biochem; 2011 Feb; 112(2):509-19. PubMed ID: 21268072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHIP participates in protein triage decisions by preferentially ubiquitinating Hsp70-bound substrates.
    Stankiewicz M; Nikolay R; Rybin V; Mayer MP
    FEBS J; 2010 Aug; 277(16):3353-67. PubMed ID: 20618441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of residues on Hsp70 and Hsp90 ubiquitinated by the cochaperone CHIP.
    Kundrat L; Regan L
    J Mol Biol; 2010 Jan; 395(3):587-94. PubMed ID: 19913553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The E3 ubiquitin ligase CHIP selectively regulates mutant epidermal growth factor receptor by ubiquitination and degradation.
    Chung C; Yoo G; Kim T; Lee D; Lee CS; Cha HR; Park YH; Moon JY; Jung SS; Kim JO; Lee JC; Kim SY; Park HS; Park M; Park DI; Lim DS; Jang KW; Lee JE
    Biochem Biophys Res Commun; 2016 Oct; 479(2):152-158. PubMed ID: 27475501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineralocorticoid receptor degradation is promoted by Hsp90 inhibition and the ubiquitin-protein ligase CHIP.
    Faresse N; Ruffieux-Daidie D; Salamin M; Gomez-Sanchez CE; Staub O
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1462-72. PubMed ID: 20861078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hsp70 and Hsp90 oppositely regulate TGF-β signaling through CHIP/Stub1.
    Shang Y; Xu X; Duan X; Guo J; Wang Y; Ren F; He D; Chang Z
    Biochem Biophys Res Commun; 2014 Mar; 446(1):387-92. PubMed ID: 24613385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.
    Schulz R; Marchenko ND; Holembowski L; Fingerle-Rowson G; Pesic M; Zender L; Dobbelstein M; Moll UM
    J Exp Med; 2012 Feb; 209(2):275-89. PubMed ID: 22271573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.